Skip NavigationSkip to Content
Return Return to Search Results

Subchronic and Chronic Toxicity Evaluation of Inorganic Nanoparticles for Delivery Applications

  1. Author:
    Mohammadpour, Raziye
    Dobrovolskaia,Marina
    Cheney, Darwin L
    Greish, Khaled F
    Ghandehari, Hamidreza

  2. Author Address

    Utah Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, Utah., Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland., Department of Molecular Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 329; Nanomedicine Research Unit, Princess Al-Jawhara Centre for Molecular Medicine and Inherited Disorders, Arabian Gulf University, Manama 329, Kingdom of Bahrain., Utah Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, Utah; Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah, United States; Department of Bioengineering, University of Utah, Salt Lake City, Utah, United States. Electronic address: hamid.ghandehari@utah.edu.,
    1. Year: 2019
    2. Date: Jul 08
    3. Epub Date: 2019 07 08
  2. Journal: Advanced drug delivery reviews
    1. 144
    2. SI
    3. Pages: 112-132
  4. Type of Article: Article
  5. ISSN: 0169-409X
  1. Abstract:

    Inorganic nanoparticles provide the opportunity to localize bioactive agents to the target sites and protect them from degradation. In many cases, acute toxicities of inorganic nanoparticles used for delivery applications have been investigated. However, little information is available regarding the long-term toxicity of such materials. This review focuses on the importance of subchronic and chronic toxicity assessment of inorganic nanoparticles investigated for delivery applications. We have attempted to provide a comprehensive review of the available literature for chronic toxicity assessment of inorganic nanoparticles. Where possible correlations are made between particle composition, physiochemical properties, duration, frequency and route of administration, as well as the sex of animals, with tissue and blood toxicity, immunotoxicity and genotoxicity. A critical gap analysis is provided and important factors that need to be considered for long-term toxicology of inorganic nanoparticles are discussed. Copyright © 2019. Published by Elsevier B.V.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.addr.2019.07.006
  3. PMID: 31295521
  4. View record in Web of Science®
  5. WOS: 000487570700008
  6. PII : S0169-409X(19)30114-0

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel